Eckert M, Schejbal P
St. Marienhospital, Lünen.
Fortschr Med. 1992 Oct 20;110(29):544-8.
In an open, multicentric observational study involving 234 doctors in private practice, the evolution of symptoms and the tolerability of a vitamin B preparation (Neurotrat forte) used as treatment in 1,149 patients with polyneuropathy, neuralgia, radiculopathy and neuritis associated with pain and paresthesias, were observed. The form of administration (ampoules, dragées), dosage and duration of treatment were left to the individual care-providing physician. The target symptoms evaluated were intensity of pain, muscle weakness affecting the legs, and paresthesia.
Under treatment, there was a clear improvement in these symptoms. At a second examination approximately three weeks after initiation of treatment, a positive effect on pain in particular was observed in 69% of the cases. Similar observations were also made for paresthesias and muscular weakness in the legs.
在一项开放性、多中心观察性研究中,对234名私人执业医生所治疗的1149例患有与疼痛和感觉异常相关的多发性神经病、神经痛、神经根病和神经炎的患者,观察了症状演变以及用作治疗的一种维生素B制剂(Neurotrat forte)的耐受性。给药形式(安瓿剂、糖衣丸)、剂量和治疗持续时间由提供个体护理的医生决定。评估的目标症状为疼痛强度、影响腿部的肌肉无力和感觉异常。
治疗期间,这些症状有明显改善。在开始治疗约三周后的第二次检查中,69%的病例尤其观察到对疼痛有积极作用。对腿部的感觉异常和肌肉无力也有类似观察结果。